Position in GERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,410,470
+$4,379,602 QoQ
Shares Held
2,960,047
+13037.1% QoQ
Ownership
0.461%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in GERN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,410,470 | 2,960,047 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $30,868 | 22,532 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,332,153 | 944,790 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,173,336 | 5,140,464 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $7,798,601 | 2,202,995 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $5,777,526 | 1,272,583 | Shares | Other | 2024-11-14 | |
| 2024-03-31 | $394,350 | 119,500 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $4,385,627 | 2,078,497 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $12,424,567 | 5,860,645 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $31,491,444 | 9,810,419 | Shares | Other | 2023-08-14 | |
| 2022-09-30 | $1,801,322 | 769,796 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||